Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1997-02-10
2000-09-19
Hutzell, Paula K.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514 12, 514479, 514529, 514533, 530350, 530380, 530381, 558276, A61K 3800
Patent
active
061212326
ABSTRACT:
A stabilized solution of fibrinogen containing samples, in particular a stabilized solution of the biological active component (BAC) which is a solution of proteins derived from blood plasma comprising fibrinogen, tranexamic acid and arginine or lysine or mixtures or arginine and lysine, their pharmaceutically acceptable salts, as well as, optionally, substances forming a buffered solution in aqueous medium.
REFERENCES:
patent: 4377572 (1983-03-01), Schwarz et al.
patent: 5278189 (1994-01-01), Rath et al.
patent: 5578326 (1996-11-01), Weis-Fogh
A. Takada, et al., "Importance Of Lysine In The Regulation Of Plasma Proteases And Inhibitors", pp. 19-20, 1983.
C. Lentner: "Geigy Scientific Tables", 1981, Ciba-Geigy, Basel XP002034353212490, pp. 92-93; tables 2-4.
Bar Lilliana
Lieberman Oded
Nur Israel
Davis Minh-Tam
Hutzell Paula K.
Omrix Biopharmaceuticals SA
LandOfFree
Stabilized mixture comprising fibrinogen does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Stabilized mixture comprising fibrinogen, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Stabilized mixture comprising fibrinogen will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1073255